| __timestamp | Amneal Pharmaceuticals, Inc. | GSK plc |
|---|---|---|
| Wednesday, January 1, 2014 | 84615000 | 8246000000 |
| Thursday, January 1, 2015 | 109679000 | 9232000000 |
| Friday, January 1, 2016 | 118757000 | 9366000000 |
| Sunday, January 1, 2017 | 109046000 | 9672000000 |
| Monday, January 1, 2018 | 230435000 | 9915000000 |
| Tuesday, January 1, 2019 | 289598000 | 11402000000 |
| Wednesday, January 1, 2020 | 326727000 | 11456000000 |
| Friday, January 1, 2021 | 365504000 | 10975000000 |
| Saturday, January 1, 2022 | 399700000 | 8372000000 |
| Sunday, January 1, 2023 | 429675000 | 9385000000 |
In pursuit of knowledge
In the competitive pharmaceutical industry, managing Selling, General, and Administrative (SG&A) expenses is crucial for profitability. Over the past decade, GSK plc and Amneal Pharmaceuticals, Inc. have shown contrasting approaches. GSK, a global leader, consistently reported SG&A expenses averaging around $9.8 billion annually, peaking in 2019 with a 14% increase from 2014. In contrast, Amneal, a smaller player, saw a dramatic rise in SG&A costs, growing by over 400% from 2014 to 2023. This surge reflects Amneal's aggressive expansion strategy. However, GSK's stable expenses suggest a more controlled cost management approach, despite its larger scale. As the industry evolves, these strategies highlight the balance between growth and cost efficiency. Understanding these dynamics offers valuable insights into the financial health and strategic priorities of pharmaceutical giants.
Gross Profit Trends Compared: GSK plc vs Amneal Pharmaceuticals, Inc.
Breaking Down SG&A Expenses: GSK plc vs ADMA Biologics, Inc.
GSK plc vs Amicus Therapeutics, Inc.: SG&A Expense Trends
GSK plc and Merus N.V.: SG&A Spending Patterns Compared
Comparing SG&A Expenses: GSK plc vs Arrowhead Pharmaceuticals, Inc. Trends and Insights
Biogen Inc. and Amneal Pharmaceuticals, Inc.: SG&A Spending Patterns Compared
Who Optimizes SG&A Costs Better? Insmed Incorporated or Amneal Pharmaceuticals, Inc.
Comparing SG&A Expenses: Amneal Pharmaceuticals, Inc. vs Viking Therapeutics, Inc. Trends and Insights
Selling, General, and Administrative Costs: Amneal Pharmaceuticals, Inc. vs Xenon Pharmaceuticals Inc.
Operational Costs Compared: SG&A Analysis of Amneal Pharmaceuticals, Inc. and PTC Therapeutics, Inc.
Comparing SG&A Expenses: Amneal Pharmaceuticals, Inc. vs Arrowhead Pharmaceuticals, Inc. Trends and Insights
Who Optimizes SG&A Costs Better? Amneal Pharmaceuticals, Inc. or Iovance Biotherapeutics, Inc.